Author:
Kotsopoulos Ioannis C.,Miller Rowan E.,Mould Timothy A.
Publisher
Springer International Publishing
Reference56 articles.
1. Herzog TJ. The current treatment of recurrent ovarian cancer. Curr Oncol Rep. 2006;8(6):448–54.
2. Eitan R, Chi DS. Secondary cytoreduction in the treatment of recurrent ovarian cancer. In: Ayhan A, et al., editors. Textbook of gynaecological oncology. Ankara: Gunes Publishing; 2017. p. 894–7.
3. Plotti F, Scaletta G, Aloisi A, Luvero D, Capriglione S, Miranda A, et al. Quality of life in platinum-sensitive recurrent ovarian cancer: chemotherapy versus surgery plus chemotherapy. Ann Surg Oncol. 2015;22(7):2387–94.
4. Berek JS, Bertelsen K, du Bois A, Brady MF, Carmichael J, Eisenhauer EA, et al. Advanced epithelial ovarian cancer: 1998 consensus statements. Ann Oncol. 1999;10(Suppl 1):87–92.
5. Eisenkop SM, Friedman RL, Spirtos NM. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer. 2000;88(1):144–53.